Summary:
- Volatility is at a recent 2 week low. A recent low volatility of stock movement within a box range could trigger break through when activities pick up.
- A moving average of short volume ratio is at a recent 2 week low. A lower short volume ratio could be a bullish signal.
- RSI is at a high level of 71. A high level of RSI indicates the stock is overbought.
- MACD is crossing MACD signal line at 0.2. MACD crossing signal line is bullish signal.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
SAN FRANCISCO, CA / ACCESSWIRE / January 15, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided the replay link for the Company's January 14, 2021 investor webcast and a recap of the key points from the presentation.
This additional non-dilutive financing will support development program for lechlemer for the indication of the symptomatic relief of diarrhea and dehydration in cholera patientsREMINDER: Jaguar-hosted investor webcast scheduled for Thursday, January 14 at 11:30 A. Webcast registration and participation link appears belowSAN FRANCISCO, CA / ACCESSWIRE / January 13, 2021 / Jaguar Health, Inc.
SAN FRANCISCO, CA / ACCESSWIRE / January 13, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced it has entered into a securities purchase agreement with two institutional investors including a high-net-worth family office for the purchase and sale of 4,437,870 shares of common stock at a purchase price of $3.
REMINDER: Jaguar-hosted investor webcast scheduled for Thursday, January 14 at 11:30 A. Webcast registration link appears belowJaguar CEO Lisa Conte interviewed on Innovators with Jane KingSAN FRANCISCO, CA / ACCESSWIRE / January 12, 2021 / Jaguar Health, Inc.
New COVID-19 strain estimated to have tripled number of infections in England during November 2020 lockdown Investor webcast scheduled for Thursday, January 14 at 11:30 A. Webcast registration link appears belowSAN FRANCISCO, CA / ACCESSWIRE / January 11, 2021 / Jaguar Health, Inc.
Shares of Jaguar Health (NASDAQ: JAGX) soared 49.3% on Friday, extending the pharmaceutical company's staggering gains since mid-November. Jaguar Health's stock price is up a stunning 2,062% since its lows on Nov. 16. Jaguar Health said the plan could involve a potential merger of its operating subsidiary with Swiss Growth Forum, a sponsor of a special purpose acquisition company (SPAC).
Lechlemer development focused on possible tropical disease priority review voucherSAN FRANCISCO, CA / ACCESSWIRE / January 6, 2021 / Jaguar Health, Inc.
Shares of Jaguar Health Inc., a developer of plant-based medicines for people and animals, soared more than 40% on Tuesday in heavy volume, extending their recent strong gains and putting the stock on track for its highest level since mid-2019.